FDA Logo links to FDA home page Skip Navigation
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website
horizonal rule

Up

2004P-0015: DENY APPROVAL OF ANY NEW DRUG APPLICATION ( NDA ) FOR RECOMBINANT SALMON CALCITONIN (RSCT ) NASAL SPRAY
Document # Received Date Filed Date Submitter Code Submitter FR Date FR Page Comment Date Files Remarks
 
CP1 01/09/2004 01/09/2004 Drug Industry Buc & Beardsley       pdf  
Signature: Nancy L. Buc
ACK1 01/09/2004 01/09/2004 Government HFA-305 to Buc & Beardsley       doc  
Signature: Jennie C. Butler
LET1 07/08/2004 07/08/2004 Federal Government
HFD-005 to Buc & Beardsley       pdf  
Signature: Jane A. Axelrad
EMC1 01/25/2005 01/25/2005 Private Industry Investor in Unigene, Inc.          
Signature: Douglas Goble
EMC2 04/11/2005 04/11/2005 Drug Industry Unigene Laboratories, Inc. (Unigene)       01, 02  
Signature: Ronald S. Levy, PhD
RC1 04/27/2005 04/27/2005 Private Industry Buc & Beardsley       pdf  
Signature: Nancy L. Buc
PDN1 08/16/2005 08/16/2005 Federal Government
HFD-001 to Buc & Beardsley       pdf  
  Signature: Steven K. Galson, MD, MPH

Top | Up

Page last updated October 12, 2005 kkhorizonal rule
Dockets Home Page | Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA

FDA/Dockets Management